Accelerate Diagnostics (NASDAQ:AXDX) reported its Q3 earnings results on Thursday, November 9, 2023 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Accelerate Diagnostics missed estimated earnings by 10.28%, reporting an EPS of $-1.18 versus an estimate of $-1.07.
Revenue was up $339 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.09 which was followed by a 2.92% increase in the share price the next day.
Here’s a look at Accelerate Diagnostics’s past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | -1.40 | -1.4 | -1.5 | -1.9 |
| EPS Actual | -1.31 | -1.7 | -1.5 | -1.8 |
| Revenue Estimate | 3.60M | 3.35M | 2.87M | 3.75M |
| Revenue Actual | 2.92M | 2.81M | 2.97M | 2.96M |
To track all earnings releases for Accelerate Diagnostics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
